Michel Mittelbronn
Latest publications
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors.
- Luxembourg Center of Neuropathology
2020 May. J Clin Invest.130(5):2488-2495.
High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma.
- Luxembourg Center of Neuropathology
2020 Jan. Pathol Res Pract.216(1):152728. Epub 2019 Nov 11.
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
- Luxembourg Center of Neuropathology
2020 Jan. Acta Neuropathol.139(1):193-209. Epub 2019 Sep 28.
Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation.
- Luxembourg Center of Neuropathology
2020 Jan. J Neurooncol.146(1):63-69. Epub 2019 Nov 11.
Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
- Luxembourg Center of Neuropathology
2019 Dec. Neurobiol Dis.132:104559. Epub 2019 Jul 31.
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases.
- Luxembourg Center of Neuropathology
2019 Oct. J Exp Clin Cancer Res.38(1):434.
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas.
- Luxembourg Center of Neuropathology
2019 Aug. Acta Neuropathol.138(2):331-334. Epub 2019 May 7.
Mistletoe-based drugs work in synergy with radio-chemotherapy in the treatment of glioma in vitro and in vivo in glioblastoma bearing mice.
- Luxembourg Center of Neuropathology
2019 Jul. Evid Based Complement Alternat Med.2019:2019/07/30.
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
- Luxembourg Center of Neuropathology
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
2019 Jul. Brain Pathol.29(4):513-529. Epub 2019 Jan 15.
Targeting APLN/APLNR improves anti-angiogenic efficiency and blunts pro-invasive side effects of VEGFA/VEGFR2-blockade in glioblastoma.
- Luxembourg Center of Neuropathology
2019 May. Cancer Res.29(9):2298-2313. Epub 2019 Feb 4.
Therapeutic targeting of Stat3 using lipopolyplex nanoparticle-formulated siRNA in a syngeneic orthotopic mouse glioma model.
- Luxembourg Center of Neuropathology
2019 Mar. Cancers.11(3).
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.
- Luxembourg Center of Neuropathology
2019 Mar. Br J Cancer.120(5):481-487. Epub 2019 Feb 12.
Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.
- Luxembourg Center of Neuropathology
2019 Feb. Neuro Oncol.21(3):326-336.
Pontine tumor in a neonate: case report and analysis of the current literature.
- Luxembourg Center of Neuropathology
2019 Feb. J Neurosurg Pediatr.23(5):606-612. [Epub ahead of print].
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype.
- Luxembourg Center of Neuropathology
2019 Feb. Clin Sarcoma Res.9:2.
Microglia in health and disease: A unique immune cell population. (Book)
- NORLUX Neuro-Oncology Laboratory
- Luxembourg Center of Neuropathology
2018 Sep. Michelucci A, Mittelbronn M and Gomez-Nicola D, eds. Lausanne: Frontiers Media, 2018. 106 p. (Frontiers Research topic). ISBN 978-2-88945-601-7.
Pre- and early postoperative GFAP serum levels in glioma and brain metastases.
- Luxembourg Center of Neuropathology
2018 Sep. J Neurooncol.139(3):541-546. Epub 2018 May 24.
EGFL7 enhances surface expression of integrin alpha5beta1 to promote angiogenesis in malignant brain tumors.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
- Luxembourg Center of Neuropathology
2018 Sep. EMBO Mol Med.10(9).
Microglia in health and disease: a unique immune cell population.
- NORLUX Neuro-Oncology Laboratory
- Luxembourg Center of Neuropathology
2018 Aug. Front Immunol.9:1779.
Adjuvant therapy using mistletoe containing drugs boosts the T-cell-mediated killing of glioma cells and prolongs the survival of glioma-bearing mice.
- Luxembourg Center of Neuropathology
2018 Jul. Evid Based Complement Alternat Med.2018:3928572.